RESTON, VA – comScore (NASDAQ: SCOR), a leader in measuring the digital world, announced the divestiture of its non-health copy-testing and non-health equity tracking assets of ARS to MSW Research (formerly McCollum Spielman Worldwide).
MSW is a global leader in advertising research, brand health, advertising tracking, neuroscience and strategic research. The new firm will be called MSW●ARS. comScore will retain the health-based copy-testing and equity tracking assets following the divestiture.
“The divestiture of certain of our ARS assets will allow us to better focus our attention on comScore’s core growth opportunities,” said Dr. Magid Abraham, comScore President & CEO. “We thank the employees of ARS for their service and dedication as part of comScore, and wish them every success with MSW.”
The financial impact of this divesture is unchanged from expectations provided in comScore’s fourth quarter earnings announcement.
About comScore
comScore, Inc. (NASDAQ: SCOR) is a global leader in digital measurement and analytics, delivering insights on web, mobile and TV consumer behavior that enable clients to maximize the value of their digital investments. For more information, please visit www.comscore.com/companyinfo.
